Harry Bleiberg Consultant Oncology
Harry Bleiberg is a medical oncologist. He was Head of the Gastroenterology Unit, Co-Director of the Chemotherapy Unit and Director of the GI Cancer Clinical Research Program at the Institute Jules Bordet, Belgium. He is still member of the Ethical Committee of that institution and editor of the electronic cancer journal e-JCancerBordet. He filled various positions within the Gastrointestinal Tract Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer since its foundation in 1972 and act as Chairman from 1988 to 1995. He was President of the Belgian Society for Medical Oncology from 2001 to 2005. Harry Bleiberg now acts as a Medical Consultant for various companies developing drugs and diagnostic devices.

Vivodiem sprl provides expert consulting services in clinical and preclinical drug metabolism and pharmacokinetics
Dr. Marc Hérin, our Manager and Consultant, has over 30 years experience in Drug Discovery and Development in ADME areas: Drug Metabolism, Pharmacokinetics, Drug Analysis and Metabolite Structure Elucidation.
We bring our industrial experience to help you define your drug development strategy and achieve your drug development objectives.
Our services cover, but are not restricted to:

Arlenda is a CRO specialized in Applied « Modeling & Statistics » for informed and timely decision making in Life Sciences.
Arlenda provides a very wide variety of services in early clinical phases, from traditional statistical report to advanced PK-PD models simulations: